This Article  • References  • Full text PDF  • Correction  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

III. JHM Virus Infection of Rats

Ole Sorensen, MSc; Dean Perry, DVM, PhD; Samuel Dales, PhD

Arch Neurol. 1980;37(8):478-484.

Abstract
• Suckling rats of three inbred and three outbred strains were inoculated intraperitoneally (IP) or intracerebrally (IC) with the JHM strain of mouse hepatitis virus (JHMV) and were monitored for evidence of neurologic diseases. Consequences of varying age at inoculation, route of injection, and virus dose were ascertained. No disease was evident after IP injection but IC inoculation with at least 10⁴ plaque-forming units at 2 days of age resulted in either a rapidly fatal encephalitis or a chronic, progressive, fatal neurologic disease in most rats, regardless of strain. Inoculation at 5 or 10 days of age predominantly caused the chronic neurologic disease, characterized by demyelinating lesions in the brain, spinal cord, or optic nerve, which sometimes were evident as late as several months postinoculation. Demyelination in the optic nerve proved to be concurrent with demyelinating lesions elsewhere in the CNS. Occasionally, clinical remissions were observed in rats in which posterior paralysis developed, suggesting that remyelination in the rat can occur. Demonstration of virus replication, by infectivity, in rats exhibiting neurologic disease and in rats without clinical symptoms was substantiated by electron microscopic observations of virus development and assembly in oligodendroglia of the optic nerve and spinal cord. In view of the protracted course of the disease in some rats, presence of demyelinating lesions confirmed by light and electron microscopy, and remissions of clinical symptoms, the JHMV-infected rat seems to be an appropriate animal model to study virusmediated progressive demyelinating disease.

Author Affiliations
From the Cytobiology Group, Departments of Microbiology and Immunology, University of Western Ontario, London.

Footnotes
Accepted for publication July 30, 1979.

Read in part at the workshop of the Multiple Sclerosis Society, New York, March, 1978.

Reprint requests to Cytobiology Group, Departments of Microbiology and Immunology, University of Western Ontario, London, Ontario, NA6 5C1, Canada.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Selection of CTL Escape Mutants in Mice Infected with a Neurotropic Coronavirus: Quantitative Estimate of TCR Diversity in the Infected Central Nervous System
Pewe et al.
J. Immunol. 1999;163:6106-6113.
ABSTRACT | FULL TEXT  

Depletion of Blood-Borne Macrophages Does Not Reduce Demyelination in Mice Infected with a Neurotropic Coronavirus
Xue et al.
J. Virol. 1999;73:6327-6334.
ABSTRACT | FULL TEXT  

Antigenic Assessment of Coronaviruses Isolated From Patients With Multiple Sclerosis
Fleming et al.
Arch Neurol 1988;45:629-633.
ABSTRACT  

Experimental Neuropathology of Chronic Demyelination Induced by a JHM Virus Variant (DS)
Erlich et al.
Arch Neurol 1987;44:839-842.
ABSTRACT  

Analysis of JHM Central Nervous System Infections in Rats
Parham et al.
Arch Neurol 1986;43:702-708.
ABSTRACT